Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?

Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible? Med J Aust. 2004 Oct 18; 181(8):457; discussion 457-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.